about
Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.Protection against Radiotherapy-Induced ToxicityOral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practiceMechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapyMicrobiome mediation of infections in the cancer settingOral Mucositis Induced By Anticancer TherapiesBiomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networksProbiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to actionTLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?Oral complications in hematopoietic stem cell recipients: the role of inflammation5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imagingOlmesartan decreased levels of IL-1β and TNF-α, down-regulated MMP-2, MMP-9, COX-2, RANK/RANKL and up-regulated SOCs-1 in an intestinal mucositis modelNon-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal CarcinomaRadiation-Induced Oral MucositisEffect of dietary boron on 5-fluorouracil induced oral mucositis in rats.Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositisNuclear factor kappaB inhibitors alleviate and the proteasome inhibitor PS-341 exacerbates radiation toxicity in zebrafish embryosRelation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer.New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal InjuryDevelopment of an in vitro model for radiation-induced effects on oral keratinocytes.Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy.Association between plasma proteome profiles analysed by mass spectrometry, a lymphocyte-based DNA-break repair assay and radiotherapy-induced acute mucosal reaction in head and neck cancer patients.IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice.Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis.Dental approach in the pediatric oncology patient: characteristics of the population treated at the dentistry unit in a pediatric oncology brazilian teaching hospital.Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in miceMASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways.Dietary transforming growth factor-beta 2 (TGF-β2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat.Preventive effect of Daiokanzoto (TJ-84) on 5-fluorouracil-induced human gingival cell death through the inhibition of reactive oxygen species productionBiomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases.Pretherapeutic plasma pro- and anti- inflammatory mediators are related to high risk of oral mucositis in pediatric patients with acute leukemia: a prospective cohort study.Oral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective studySaireito (TJ-114), a Japanese traditional herbal medicine, reduces 5-fluorouracil-induced intestinal mucositis in mice by inhibiting cytokine-mediated apoptosis in intestinal crypt cells.R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.The influence of oral bacteria on epithelial cell migration in vitro
P2860
Q24282585-7A047B59-86D9-4F8B-97BB-849177DA37BDQ26741273-5A003FA8-CB11-4872-A149-E423FD4315A1Q26743390-20247225-EEAF-4EB6-9134-CD64A5ABC5EBQ26751146-E0AC31A6-06A3-477F-9BE6-88BD5D20AA76Q26752672-587E2CCA-99DA-4AE1-9042-C39A29C1B195Q26777493-BC5F75F6-5E03-4572-B428-A67EFFC3E23EQ26991945-54702EF6-DB64-4DBF-9260-AE0B7703D98DQ27012716-61E4BEE4-A041-4D3B-8FA7-269A6F110693Q27015742-6CFC5CBA-1D4E-47D2-BC3F-DB2CFE92B918Q27027650-1D003E7A-6F9B-4352-BC70-FC05E2651798Q28481421-70FE5B90-7087-4AEC-8A27-2C19F1D40D57Q28542802-82F58E5B-0297-4877-A0C2-CBAE3CA96DC3Q33557148-0F4BF926-1077-4A6B-A304-8CC9674209B2Q33594436-77AFD53D-E49D-4F62-9CB3-17884A3EC31FQ33603216-B47171AD-32BB-4323-9E85-E5F37E9FB1B2Q33711362-D35FA564-612E-4C7F-A548-CE230E2F7D39Q33741338-90BC8435-9DE5-4438-BF54-E4ED9F7FDF2EQ33753588-437219C3-B020-4E39-B7F7-22679C06AF87Q33757740-BF9FAC64-5543-4EA1-94BD-D4302D7B5BD6Q33771732-895FF127-981F-4B56-93F6-9C9D6B33AB51Q33774917-B216B9AC-B541-4136-92D3-EA047862729EQ33811759-2689D7FE-80E7-4069-808F-56182F77843EQ33826398-2D0F8F94-C1A8-4841-8326-D6C99F44317FQ33829971-2E29AAED-9238-456A-83B4-CADE450797A0Q33830896-AE4272BC-9F82-44E9-A766-80F11C61430CQ33874148-CF0D9744-B11D-49BF-B751-F5A95374EDDCQ33967841-C9D09F96-B94D-4174-B08E-FFAE94824768Q34023501-9CAA9B7D-F85E-4ECC-A9F0-B1873AA2936FQ34080590-DFCA0785-E3DE-43FF-8A02-9998A24F9B57Q34180792-73FB9757-BC90-476D-B70C-9B891EC42641Q34220376-1EC166E3-026E-4A05-9574-5CE13D3D6FE1Q34416431-9D0DFA0B-826A-4E35-AF9B-51FFEDD6FA33Q34497892-05A1E809-A159-4F4F-B1D6-A8F21DC0BE43Q34581943-24C0FC76-7DE9-443F-946E-348D11550E95Q34760995-DD73ABB5-AA8E-405C-A0C2-9805C18AC086Q34799946-697452F0-55FD-4903-800F-3B269CFF29B5Q34856264-44D1CD76-6214-4867-B54D-6661563AEF59Q34932642-6616C119-1BCB-41E2-ABBF-FCC7CF4F8895Q35022269-CF246AA1-1A05-46A8-8D28-72D3F6B053B9Q35056337-27BA5BB0-7DE9-445F-AEDF-9CC3B716D745
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The pathobiology of mucositis.
@ast
The pathobiology of mucositis.
@en
type
label
The pathobiology of mucositis.
@ast
The pathobiology of mucositis.
@en
prefLabel
The pathobiology of mucositis.
@ast
The pathobiology of mucositis.
@en
P356
P1476
The pathobiology of mucositis.
@en
P2093
Stephen T Sonis
P2888
P304
P356
10.1038/NRC1318
P407
P577
2004-04-01T00:00:00Z
P6179
1026773283